Skip to content

Our latest paper in collaboration with Pfizer on the role of OCT2/MATE in creatinine clearance is accepted in JPET.

Covid-19 action plan – 2021 update

Covid 19 Update Banner

In line with our previous Covid-19 Action Plan, Newcells Biotech has continued to review and invest in measures to reduce the risk to its staff and our wider community from the Covid-19 virus.

We have reviewed our policies and procedures in light of the recent Government restrictions and implemented further measures including improved physical barriers, biosecurity procedures and work patterns to enable us to continue servicing our customers while maintaining the safety of our staff.

We wish all of our customers, suppliers and partners a safe and healthy 2021.

Dr Mike Nicholds
Newcells Biotech

Don't miss out on our latest innovations: follow us on Linkedin


13th January, 2021



Get our latest updates straight to your inbox